FindTrial
Sign In

Circulating tumor DNA assay

DIAGNOSTIC_TEST2 trials

Sponsors

British Columbia Cancer Agency, University of British Columbia

Conditions

Carcinoma, Non-Small-Cell LungCirculating Tumor CellsLung Adenocarcinoma, Stage ILung CancerLung Cancer Stage ILung Squamous Cell Carcinoma Stage INon Small Cell Lung CancerNon-small Cell Lung Cancer Stage I

Phase 2

SCION: SABR and Checkpoint Inhibition of NSCLC
WithdrawnNCT04944173
University of British ColumbiaCarcinoma, Non-Small-Cell Lung, Lung Adenocarcinoma, Stage I, Lung Cancer +4
Start: 2023-08-11End: 2027-06-30Updated: 2024-09-03

Unknown Phase

Cancer DNA Screening Pilot Study (CANDACE)
CompletedNCT02808884
British Columbia Cancer AgencyCirculating Tumor Cells
Start: 2016-09-19End: 2019-06-10Updated: 2020-08-24